I was around in May 2006 and at that time there was no drug in the pipeline. A good concept had been developed and, pre-GFC, it was hoped a major pharma would grab the concept. Post-GFC and most big companies changed their investment risk profiles and PYC languished for a long time. This time is very different - new leadership, drugs in pipeline, clear strategy and a much clearer understanding of the technology capabilities.
I was around in May 2006 and at that time there was no drug in...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
